Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Sci Adv ; 7(11)2021 03.
Article in English | MEDLINE | ID: mdl-33712458

ABSTRACT

Increased levels of apolipoprotein CIII (apoCIII), a key regulator of lipid metabolism, result in obesity-related metabolic derangements. We investigated mechanistically whether lowering or preventing high-fat diet (HFD)-induced increase in apoCIII protects against the detrimental metabolic consequences. Mice, first fed HFD for 10 weeks and thereafter also given an antisense (ASO) to lower apoCIII, already showed reduced levels of apoCIII and metabolic improvements after 4 weeks, despite maintained obesity. Prolonged ASO treatment reversed the metabolic phenotype due to increased lipase activity and receptor-mediated hepatic uptake of lipids. Fatty acids were transferred to the ketogenic pathway, and ketones were used in brown adipose tissue (BAT). This resulted in no fat accumulation and preserved morphology and function of liver and BAT. If ASO treatment started simultaneously with the HFD, mice remained lean and metabolically healthy. Thus, lowering apoCIII protects against and reverses the HFD-induced metabolic phenotype by promoting physiological insulin sensitivity.


Subject(s)
Diet, High-Fat , Metabolic Diseases , Adipose Tissue, Brown/metabolism , Animals , Apolipoprotein C-III/metabolism , Diet, High-Fat/adverse effects , Metabolic Diseases/metabolism , Mice , Mice, Inbred C57BL , Obesity/etiology , Obesity/metabolism , Obesity/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...